Chroneme interprets the trajectory before there is a reason to look. Every signal, from every provider, across years. No black box, by design. Intelligence clinicians can question, understand, and trust.
We tested Chroneme on data from 208 hospitals, across 49,850 ICU stays. It detected deterioration more than 35 hours before standard scoring systems flagged anything. When the same engine moved to an independent database, 99.4% of performance was retained.
Zohaib Akhtar is the founder of Chroneme. His cross-disciplinary background spans medicine, public health, biomedical design, business, and AI systems. Also founder of OpenCura. 13 patent families filed.
Chenyu Li, Co-Founder. Adam Wolfe, Co-Founder.
Founded 2025. Chroneme, Inc. 13 patent families filed. Contact: mail@chroneme.com
For most of medical history, seeing a patient required being in the room. Distance and time were physical limits on what medicine could do. Sensors, continuous data, and the math for reading multi-signal trajectories at scale are now giving medicine a new sense: continuous perception of how a person's health changes across time.
NASA has been building the foundations of this from the inside for decades, through bioastronautics research, ISS crew health monitoring, and now the Artemis program. SpaceX, Axiom Space, and Blue Origin are extending crew health work to commercial spaceflight. DARPA and USSOCOM are doing the parallel work for special operators and pilots.
Chroneme is the layer that reads health across time. The same architecture that reads a slow drift in an ICU reads a driver's fatigue across six months on the road, an athlete's accumulating wear across a season, or an astronaut's cardiovascular signals across a mission. Validated on ICU data from more than 200 hospitals. Identifies clinical deterioration hours to days earlier than standard early warning scores.